News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,958 Results
Type
Article (86595)
Company Profile (702)
Press Release (761661)
Multimedia
Podcasts (134)
Webinars (16)
Section
Business (232725)
Career Advice (4128)
Deals (39730)
Drug Delivery (129)
Drug Development (91008)
Employer Resources (198)
FDA (18135)
Job Trends (17345)
News (396566)
Policy (39767)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (96)
Alliances (56879)
ALS (108)
Alzheimer's disease (1524)
Antibody-drug conjugate (ADC) (169)
Approvals (18081)
Artificial intelligence (352)
Autoimmune disease (31)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (90)
Brain cancer (33)
Breast cancer (336)
Cancer (2636)
Cardiovascular disease (220)
Career advice (3535)
Career pathing (34)
CAR-T (189)
Cell therapy (528)
Cervical cancer (22)
Clinical research (73661)
Collaboration (968)
Company closure (2)
Compensation (603)
Complete response letters (30)
COVID-19 (2882)
CRISPR (58)
C-suite (290)
Cystic fibrosis (113)
Data (2587)
Decentralized trials (2)
Denatured (47)
Depression (58)
Diabetes (316)
Diagnostics (6946)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (160)
Drug pricing (141)
Drug shortages (34)
Duchenne muscular dystrophy (113)
Earnings (97374)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130660)
Executive appointments (826)
FDA (19644)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (876)
Gene editing (134)
Generative AI (36)
Gene therapy (391)
GLP-1 (873)
Government (5187)
Grass and pollen (6)
Guidances (178)
Healthcare (20895)
Huntington's disease (26)
IgA nephropathy (33)
Immunology and inflammation (159)
Immuno-oncology (2)
Indications (31)
Infectious disease (3048)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (61)
Intellectual property (108)
Interviews (813)
IPO (17857)
IRA (52)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (12)
Labor market (49)
Layoffs (570)
Leadership (24)
Legal (10121)
Liver cancer (82)
Lung cancer (373)
Lymphoma (182)
Machine learning (9)
Management (65)
Manufacturing (389)
MASH (89)
Medical device (14661)
Medtech (14666)
Mergers & acquisitions (22485)
Metabolic disorders (845)
Multiple sclerosis (95)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2179)
NextGen: Class of 2025 (7684)
Non-profit (5084)
Now hiring (43)
Obesity (447)
Opinion (279)
Ovarian cancer (86)
Pain (107)
Pancreatic cancer (94)
Parkinson's disease (175)
Partnered (25)
Patents (269)
Patient recruitment (127)
Peanut (51)
People (65429)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22739)
Phase II (32002)
Phase III (24077)
Pipeline (1551)
Policy (192)
Postmarket research (3552)
Preclinical (10273)
Press Release (72)
Prostate cancer (120)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (460)
Real estate (7396)
Recruiting (75)
Regulatory (26893)
Reports (61)
Research institute (2661)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (9)
RSV (51)
Schizophrenia (84)
Series A (151)
Series B (100)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4296)
State (2)
Stomach cancer (16)
Supply chain (77)
Tariffs (59)
The Weekly (85)
Vaccines (837)
Venture capitalists (47)
Weight loss (310)
Women's health (42)
Worklife (20)
Date
Today (144)
Last 7 days (721)
Last 30 days (3952)
Last 365 days (35454)
2025 (14497)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (65)
Alaska (7)
Arizona (273)
Arkansas (14)
Asia (50250)
Australia (8847)
California (7067)
Canada (2193)
China (611)
Colorado (302)
Connecticut (319)
Delaware (176)
Europe (115348)
Florida (1031)
Georgia (240)
Hawaii (1)
Idaho (65)
Illinois (668)
India (31)
Indiana (357)
Iowa (14)
Japan (192)
Kansas (115)
Kentucky (29)
Louisiana (16)
Maine (72)
Maryland (1024)
Massachusetts (5384)
Michigan (261)
Minnesota (446)
Mississippi (3)
Missouri (94)
Montana (32)
Nebraska (26)
Nevada (75)
New Hampshire (72)
New Jersey (1967)
New Mexico (31)
New York (1983)
North Carolina (1182)
North Dakota (10)
Northern California (3041)
Ohio (236)
Oklahoma (15)
Oregon (48)
Pennsylvania (1527)
Puerto Rico (16)
Rhode Island (36)
South America (1653)
South Carolina (30)
South Dakota (1)
Southern California (2612)
Tennessee (113)
Texas (1058)
United States (26780)
Utah (206)
Virginia (192)
Washington D.C. (74)
Washington State (638)
West Virginia (4)
Wisconsin (77)
There are 848,958 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immix Biopharma Further Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
May 23, 2025
·
5 min read
Press Releases
Curatis discloses Corticorelin as active substance of C-PTBE-01
May 23, 2025
·
6 min read
Press Releases
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
May 23, 2025
·
1 min read
Press Releases
SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
May 23, 2025
·
13 min read
Press Releases
ENHERTU® (trastuzumab deruxtecan) Receives Time-Limited Reimbursement Recommendation from Canada’s Drug Agency for Gastric Cancer
May 23, 2025
·
6 min read
Press Releases
Perimeter Partners with Intermountain Health to Study the Potential Clinical, Social and Economic Benefits of Using OCT and AI to Reduce Cancer Reoperations
May 23, 2025
·
6 min read
Press Releases
Verismo Therapeutics Provides Updates on Upcoming Poster Presentation at ASCO 2025
May 23, 2025
·
4 min read
Press Releases
Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting
May 23, 2025
·
6 min read
Press Releases
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
May 23, 2025
·
2 min read
Press Releases
Autobahn Therapeutics Announces Presentation of ABX-002 Phase 1 Clinical Results at the 2025 ASCP Annual Meeting
May 23, 2025
·
3 min read
1 of 84,896
Next
